Does Wegovy Cause Hair Loss? What the Evidence Actually Says

Is hair loss listed as a Wegovy side effect?

Alopecia does not appear in the Wegovy SmPC under the "common" or "very common" frequency bands, which means clinical trials did not record it in more than 1 in 100 participants at a rate that cleared the threshold for formal listing. That is not the same as saying it doesn't happen. Post-marketing surveillance, patient registries, and the broader semaglutide clinical programme have all captured hair thinning as a real, if infrequent, experience during treatment, and our dedicated Wegovy hair loss page covers what that evidence currently looks like. The full Wegovy side-effect profile is dominated by gastrointestinal symptoms — nausea, constipation, indigestion — and those are the effects that receive most clinical attention in trial reporting.

The honest position is this: hair loss from Wegovy is reported, it has a plausible biological explanation, and it is almost always temporary. Knowing the mechanism matters, because it changes what you can do about it.

If you want the broader picture of what semaglutide does and how Wegovy works, the Wegovy overview page covers the pharmacology and licensed uses in the UK without the clinical-trial jargon.

Why does weight loss cause hair to shed, and does semaglutide make it worse?

Hair follicles are metabolically expensive. When the body faces a significant caloric or nutritional deficit, it deprioritises hair growth in favour of organs and tissue repair. The result is telogen effluvium: a large cohort of hair follicles shifts simultaneously into the resting (telogen) phase. Two to four months later, that hair falls out. The timing is confusing. You lose the weight in month one; the hair starts going in month three or four. People understandably blame the injection they are still using rather than the rapid energy deficit from weeks earlier.

Semaglutide suppresses appetite substantially. If protein intake drops alongside total calories, the shedding risk rises. Low ferritin (stored iron) is a separate but common co-factor, particularly in women, and is worth checking with your GP if shedding is noticeable. The STEP 1 trial, published in the New England Journal of Medicine, demonstrated average weight reductions of around 15% over 68 weeks at the 2.4mg maintenance dose, a degree of loss that, for many participants, represents the fastest weight change of their lives. Rapid loss is the common thread in telogen effluvium cases, whatever the cause.

The side effects of Wegovy hair loss reports tend to cluster in the first few months of treatment, and our semaglutide and hair loss page explores the mechanism across the full semaglutide product family.

When does hair grow back, and what actually helps?

For most people, shedding slows as weight stabilises and nutrition improves. Hair regrowth follows, usually within six months of the trigger, though a full recovery in density can take up to a year. That timeline frustrates people understandably. You can look at a fuller scalp as a finish line, but it's a slow one.

What the evidence supports in terms of mitigation: prioritise protein at every meal (clinical dietitians typically recommend at least 1.2–1.6g per kilogram of body weight during active weight loss), stay hydrated, check ferritin and thyroid function with your GP if shedding is marked, and avoid aggressive chemical or heat treatments while hair is more fragile. No supplement has strong trial evidence for reversing telogen effluvium, but addressing a genuine deficiency (iron, vitamin D, biotin if actually low) is sensible.

Our prescribers discuss nutrition and side-effect management as part of the consultation. If you are weighing up treatment and want to understand the full picture, what we know about hair loss from Wegovy goes into more practical detail on timelines and what patients report.

When should you get medical help for hair loss on Wegovy?

Telogen effluvium is diffuse, the shedding is spread evenly across the scalp. If you notice patchy loss, bald spots, or loss at the hairline in a defined pattern, that is a different clinical picture and warrants a GP appointment promptly. Likewise, if shedding is severe enough to cause visible thinning within weeks rather than months, or if it is accompanied by fatigue, cold intolerance, or skin changes, thyroid function should be checked.

From a Wegovy safety standpoint, the side effects requiring urgent medical attention are not hair-related. Severe, persistent stomach pain that radiates to the back, with or without vomiting, needs same-day assessment because pancreatitis is a known but infrequent risk with GLP-1 medicines, as the MHRA's Yellow Card reporting system and clinical guidance both emphasise. Any suspected side effect (including unexpected or severe hair loss) can and should be reported through Yellow Card. It contributes to the post-marketing surveillance that improves safety for future patients. You can also read more about whether hair loss is a recognised side effect of Wegovy and what reporting looks like in practice.

If you have concerns about suitability or existing conditions, our clinical team profile is at our prescribers page, and general questions are answered in our FAQs. For anything safety-related that feels urgent, contact your GP or call 111.